Participants 83 120 5
patients with chronic kidney disease.
Participants 176 234 4
patients with chronic kidney disease (CKD) not on dialysis
Participants 717 868 3
his was a post hoc analysis of a subgroup of patients from a study that evaluated the impact of two phosphorus binder regimens on hard outcomes in CKD.
Participants 869 1066 7
Patients (n = 113) with stage 3-4 CKD and evidence of CAC on a phosphorus-restricted diet were randomized to receive either calcium carbonate or sevelamer added to their phosphorus-restricted die
